Qisi Sun, MD; Sarah Asch, MD; Cheryl Bayart, MD; et al.
free access
JAMA Dermatol. 2022;158(4):359-365. doi:10.1001/jamadermatol.2021.5917
This qualitative study describes a comprehensive and user-friendly instrument to measure total body ichthyosis severity in adults and children.
Daniel Mosallaei, BS; Michelle Hao, MD; Richard J. Antaya, MD; et al.
free access
JAMA Dermatol. 2022;158(4):366-374. doi:10.1001/jamadermatol.2021.5992
This nonrandomized clinical trial of patients with junctional epidermolysis bullosa assesses whether treatment with intravenous gentamicin can safely increase laminin 332 expression.
Francesco Bellinato, MD; Giovanni Adami, MD; Silvia Vaienti, MD; et al.
free access
JAMA Dermatol. 2022;158(4):375-381. doi:10.1001/jamadermatol.2021.6019
This study examines whether there is an association between short-term exposure to air pollution and psoriasis flares.
Aubriana M. McEvoy, MD, MS; Kristina Lachance, MS; Daniel S. Hippe, MS; et al.
free access
has audio
JAMA Dermatol. 2022;158(4):382-389. doi:10.1001/jamadermatol.2021.6096
This cohort study estimates the risk of stage-specific Merkel cell carcinoma recurrence and mortality over time since diagnosis.
-
Podcast:
Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis
Timothy D. Smile, MD; Emily S. Ruiz, MD, MPH; Kylee J. B. Kus, BS; et al.
free access
JAMA Dermatol. 2022;158(4):390-394. doi:10.1001/jamadermatol.2022.0001
This multi-institutional cohort study of patients with cutaneous squamous cell carcinoma examines the association of satellitosis or in-transit metastasis with clinical outcomes to determine prognostic implications.
Rohail Memon, BA; Abdullah Memon, MD; Joseph Francis, MD; et al.
free access
has active quiz
JAMA Dermatol. 2022;158(4):395-403. doi:10.1001/jamadermatol.2022.0009
This cross-sectional study examines the valuations of dermatology private equity鈥揵acked group debt instruments in business development corporations鈥� portfolios both before and during the COVID-19 pandemic.
Eric L. Simpson, MD; Kim A. Papp, MD; Andrew Blauvelt, MD; et al.
open access
JAMA Dermatol. 2022;158(4):404-413. doi:10.1001/jamadermatol.2022.0029
This analysis of 2 randomized clinical trials evaluates long-term (52 weeks) efficacy and safety of upadacitinib treatment in patients with atopic dermatitis.
Michael R. Sargen, MD; Elizabeth K. Cahoon, PhD; Kelly J. Yu, MPH, PhD; et al.
free access
has audio
JAMA Dermatol. 2022;158(4):414-425. doi:10.1001/jamadermatol.2022.0036
This cohort study examines the spectrum of disease and risk factors for nonkeratinocyte skin cancers in solid organ transplant recipients.
-
Podcast:
Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients
Adewole S. Adamson, MD, MPP; Elizabeth A. Suarez, PhD; H. Gilbert Welch, MD, MPH
free access
JAMA Dermatol. 2022;158(4):426-431. doi:10.1001/jamadermatol.2022.0139
This cohort study used trends for mortality due to melanoma among Black patients in the US as a marker to estimate melanoma incidence among White patients in the US.
Melissa Butt, DrPH; Andrea Rigby, PsyD; Douglas L. Leslie, PhD; et al.
free access
JAMA Dermatol. 2022;158(4):432-438. doi:10.1001/jamadermatol.2022.0248
This cross-sectional study of patients with hidradenitis suppurativa evaluates internalized skin bias to determine if it mediates the associations between adverse psychopathological outcomes and impaired health-related quality of life.